| OMED Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the OMED market cap history going back to 8/23/2013:
Also see: OMED Shares Outstanding History and OMED YTD Return |
OMED Market Cap History — OncoMed Pharmaceuticals Capitalization Over Time
As of 3/5/2019 OncoMed Pharmaceuticals has a market cap of 30.95 million. Investors often follow the OMED market cap history to compare the size of the company over time.
This page shows OMED market capitalization trends over time, with 23 market cap datapoints presented, dating back to 8/23/2013.
| OMED Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||
OMED Historical Market Cap: -38.81% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||
| OMED Stock Price Chart |
| About OncoMed Pharmaceuticals Inc. |
| OncoMed Pharmaceuticals is a clinical-stage biopharmaceutical company. Co. has four anti-cancer therapeutic candidates: Navicixizumab, which is a bispecific monoclonal antibody that targets and inhibits both Delta-like ligand 4, and vascular endothelial growth factor; Anti-TIGIT, which is an inhibitory receptor that stops T-cells from attacking certain tumor cells; GITRL-Fc, which is engineered using a single-gene, linkerless trimer technology that is designed to enable activation of glucocorticoid-induced tumor necrosis factor receptor-related protein; and Rosmantuzumab, which is a monoclonal antibody targeting the RSPO-LGR cancer stem cell pathway. We show 23 historical shares outstanding datapoints in our OMED shares outstanding history coverage, used to compute OMED market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing OMED market cap history over the course of time is important for investors interested in comparing OMED's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of OMED versus a peer is one thing; comparing OMED market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like OMED can fluctuate over the course of history. With this page we aim to empower investors researching OMED by allowing them to research the OMED market cap history. |
| OMED Current Stock Quote |
Quotes delayed 20 minutes  Free OMED Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| OMED Share Performance |
| Market Cap Peers |
| OncoMed Pharmaceuticals (OMED) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
OMER Market Cap History OMGA Market Cap History OMI Market Cap History OMIC Market Cap History ONCE Market Cap History ONCR Market Cap History ONCS Market Cap History ONCT Market Cap History ONCY Market Cap History ONEM Market Cap History More Healthcare companies » |
OMED Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
